New Drug Approved for Lou Gehrig’s disease by the FDA

For the first time in nearly two decades, a drug has been approved to treat amyotrophic lateral sclerosis, which is commonly referred to as Lou Gehrig’s disease. The drug, Radicava, is only the second drug to be approved by the FDA for this particular disease. In a...

Researchers Report 70% Activity Boost from “Exercise in a Pill”

Researchers have given mice a boost at the Salk Institute, noting that the mice which received an “exercise in a pill” like drug ran on the treadmill 70% longer than those who did not receive the pill. The pill works by stimulating the PPARD gene. Researchers are...

Pfizer and Merck Surpass Quarterly Earnings Expectations

Pfizer and Merck have reported profit rises in the first quarter of 2017, signaling a positive year for the life science industry. Pfizer out-earned its projected Q1 profits with sales of breast cancer drug Ibrance and pain reliever Lyrica. Ibrance is expected to see...

Outset Medical Raises Funding for All-In-One Dialysis Device

Outset Medical has raised $76.5 million in a Series C round for its Tablo Hemodialysis System. The all-in-one dialysis device is meant to help patients access lower cost and labor intensive dialysis care. The device eliminates the need for centralized water processing...